CTSO
Cytosorbents Corp
Key Financials
Net Income
$-8198000
↑ 60.4%
Revenue
$22.5M
↑ 270.1%
Operating Income
$-14749000
↑ 12.1%
EPS (Diluted)
$-0.13
↑ 65.8%
Gross Profit
$26.5M
↑ 5.4%
Total Assets
$44.2M
↓ 6.7%
Total Liabilities
$38.3M
↑ 5.6%
Shareholders' Equity
$5.9M
↓ 46.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTSO |
| Company Name | Cytosorbents Corp |
| CIK | 1175151 |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-329-8885 |